56 Participants Needed

Financial Navigation and Peer Support for Diabetes

(FNaPS Trial)

MR
Overseen ByMinal R. Patel, Ph.D, M.P.H
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Michigan
Must be taking: Anti-hyperglycemic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to help people with diabetes manage their health and financial challenges. It tests two approaches: one group receives assistance navigating healthcare costs using special software, while the other group receives the same financial help plus support from peers who have faced similar challenges. The study will determine if adding peer support leads to better health outcomes and reduced financial stress. Participants with diabetes who take medication and struggle with healthcare costs are sought. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance support systems for managing diabetes and healthcare costs.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are taking a medication that alters glucose metabolism, you may not be eligible to participate.

What prior data suggests that this intervention strategy is safe?

Research has shown that financial navigation, with or without peer support, is generally safe for people with diabetes. Studies indicate that peer support can improve blood sugar and blood pressure control in diabetes patients, suggesting that adding peer support to financial navigation does not introduce new safety concerns.

Research also shows that financial navigation alone can enhance blood sugar control and increase clinic visits, indicating that this approach is well tolerated and poses no significant risks.

Both strategies are non-invasive and emphasize support rather than medical treatment, making physical side effects unlikely. Participants have reported benefits in managing their condition with these methods, without significant negative effects.12345

Why are researchers excited about this trial?

Researchers are excited about the trial with Financial Navigation and Peer Support for diabetes because it tackles the financial barriers that often hinder effective diabetes management. Unlike traditional diabetes treatments that focus on medications and lifestyle changes, these interventions integrate financial navigation using software called TailorMed, which helps patients manage the costs associated with their care. The addition of peer support, involving trained community members from Michigan Medicine, offers emotional and practical guidance, creating a more holistic support system. This approach could lead to better adherence to treatment plans by alleviating financial stress and providing community-based encouragement, potentially leading to improved health outcomes.

What evidence suggests that this trial's treatments could be effective for diabetes?

This trial will compare two approaches: Financial Navigation and Peer Support, and Financial Navigation Only. Studies have shown that peer support can help people with type 2 diabetes improve blood sugar and blood pressure. Research indicates that peer support programs often lead to better diabetes management. Additionally, helping patients understand their finances has been linked to better diabetes knowledge and improved blood sugar levels. Financial guidance can positively affect diabetes management and self-care. Overall, both financial guidance and peer support show promise in helping people manage diabetes more effectively.678910

Are You a Good Fit for This Trial?

This trial is for adults aged 18-75 with diabetes who have experienced financial burden or cost-related non-adherence to treatment. They must be willing to share personal health information, have a recent HbA1c level of ≥7.5% (or >8.0% if between 70-75 years), and take prescribed anti-hyperglycemic medication.

Inclusion Criteria

Participants must have a positive report of financial burden or cost-related non-adherence (CRN) using screening questions developed and validated from prior work
Participants must be willing to provide personal health information in order to effectively participate in the intervention
Peer Supporters must have an International Classification of Diseases (ICD)-10 code for diabetes
See 4 more

Exclusion Criteria

Participants with active alcohol or illicit drug use
Peer Supporters with active alcohol or illicit drug use
Participants with a diagnosis of a serious psychiatric disorder (e.g., schizophrenia)
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete a baseline survey assessment, an HbA1C test, and two blood pressure readings over the phone

1 week
1 visit (virtual)

Intervention

Participants receive either financial navigation only or financial navigation combined with peer support

6 months
3 visits (virtual) at baseline, 3 months, and 6 months

Follow-up

Participants are monitored for changes in A1c, blood pressure, and other secondary outcomes

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Financial Navigation and Peer Support
  • Financial Navigation Only
Trial Overview The study tests the impact of technology-supported financial navigation alone versus combined with peer support on diabetes management outcomes. It measures A1c levels, blood pressure, out-of-pocket costs, stress related to finances, adherence behaviors, distress from diabetes, self-care actions, and use of social care resources.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Financial Navigation and Peer SupportActive Control1 Intervention
Group II: Financial Navigation onlyActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

Published Research Related to This Trial

Peer support can enhance self-management for people with diabetes by providing essential resources and support tailored to specific cultural and health system contexts, focusing on daily management, emotional support, and connections to clinical care.
The Robert Wood Johnson Foundation Diabetes Initiative identified key functions of peer support that can be adapted locally, emphasizing the importance of measuring implementation and participant feedback to evaluate the effectiveness of these programs.
Cross-cultural and international adaptation of peer support for diabetes management.Fisher, EB., Earp, JA., Maman, S., et al.[2022]
A 3-month diabetes self-management education (DSME) program alone did not lead to improvements in glycated hemoglobin (HbA1c) levels for either the peer support or control group over 15 months.
However, participants who received 12 months of peer support after the DSME program showed significant improvements in cardiovascular disease risk factors, including lower cholesterol, blood pressure, and body mass index, compared to those who only received the DSME program.
Peer-Led, Empowerment-Based Approach to Self-Management Efforts in Diabetes (PLEASED): A Randomized Controlled Trial in an African American Community.Tang, TS., Funnell, MM., Sinco, B., et al.[2022]
Peer support programs can significantly enhance social and emotional support for adults with diabetes, helping them manage their condition more effectively between healthcare visits.
These programs not only assist with daily diabetes management but also promote connections to clinical care, indicating a promising avenue for improving patient outcomes.
Different models to mobilize peer support to improve diabetes self-management and clinical outcomes: evidence, logistics, evaluation considerations and needs for future research.Heisler, M.[2022]

Citations

Long-Term Effects of Financial Incentives for General ...To assess both long-term effects and sustainability of financial incentives for general practitioners (GPs) in the treatment of patients with diabetes mellitus.
The impact of patient navigation on glycemic control ...After the intervention, glycemic control improved in 37 (24.3%) participants (p < 0.001), and knowledge about diabetes also improved in 37 (24.3 ...
Financial Navigation and Peer Support to Improve Diabetes ...We are engaging 50 patients with uncontrolled diabetes and unmet social risk factors. Outcomes will be assessed at baseline and 3- and 6-month follow-up via ...
Effectiveness of a digital health and financial incentive ... - TrialsThis study will provide new evidence of the long-term effectiveness of an activity rewards scheme focused on increasing physical activity conducted within ...
Community to clinic navigation to improve diabetes outcomesPrimary outcomes included: (1) changes in HbA1c, blood pressure, lipids, and BMI and (2) changes in self-management activities (blood glucose monitoring, diet, ...
Patient navigation to improve diabetes outpatient care at a ...Navigation was associated with improved glycemic control and better clinic engagement among patients with diabetes.
Patient navigation to improve diabetes outpatient care at a ...The objective of this study was to evaluate the effect of a patient navigation program on medical and administrative outcomes among patients ...
Financial Navigation and Peer Support for DiabetesTrial Overview The study tests the impact of technology-supported financial navigation alone versus combined with peer support on diabetes management outcomes.
Type 2 Diabetes and Financial Outcomes | Public HealthPatients with diabetes experienced more adverse financial outcomes (1.9 vs 1.2) and had lower credit scores (mean [SE], 618.7 [0.4] vs 664.2 [ ...
Financial Toxicity in Diabetes: The State of What We KnowData indicates 30–60% of diabetes patients experience financial toxicity, with household expenditures ranging from 5 to 40% of income on ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security